Unknown

Dataset Information

0

Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.


ABSTRACT: Cancer stem cells (CSCs) drive tumour spread and therapeutic resistance, and can undergo epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) to switch between epithelial and post-EMT sub-populations. Examining oral squamous cell carcinoma (OSCC), we now show that increased phenotypic plasticity, the ability to undergo EMT/MET, underlies increased CSC therapeutic resistance within both the epithelial and post-EMT sub-populations. The post-EMT CSCs that possess plasticity exhibit particularly enhanced therapeutic resistance and are defined by a CD44(high)EpCAM(low/-) CD24(+) cell surface marker profile. Treatment with TGF? and retinoic acid (RA) enabled enrichment of this sub-population for therapeutic testing, through which the endoplasmic reticulum (ER) stressor and autophagy inhibitor Thapsigargin was shown to selectively target these cells. Demonstration of the link between phenotypic plasticity and therapeutic resistance, and development of an in vitro method for enrichment of a highly resistant CSC sub-population, provides an opportunity for the development of improved chemotherapeutic agents that can eliminate CSCs.

SUBMITTER: Biddle A 

PROVIDER: S-EPMC4776071 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.

Biddle Adrian A   Gammon Luke L   Liang Xiao X   Costea Daniela Elena DE   Mackenzie Ian C IC  

EBioMedicine 20160109


Cancer stem cells (CSCs) drive tumour spread and therapeutic resistance, and can undergo epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) to switch between epithelial and post-EMT sub-populations. Examining oral squamous cell carcinoma (OSCC), we now show that increased phenotypic plasticity, the ability to undergo EMT/MET, underlies increased CSC therapeutic resistance within both the epithelial and post-EMT sub-populations. The post-EMT CSCs that posses  ...[more]

Similar Datasets

2016-01-12 | E-GEOD-74578 | biostudies-arrayexpress
2016-01-12 | E-GEOD-74580 | biostudies-arrayexpress
2016-01-12 | GSE74580 | GEO
2016-01-12 | GSE74578 | GEO
| S-EPMC6345809 | biostudies-other
| S-EPMC5454033 | biostudies-literature
| S-EPMC4978817 | biostudies-literature
2024-06-30 | PRJEB77007 | EVA
| S-EPMC6721547 | biostudies-other
| S-EPMC5958807 | biostudies-literature